VEGFA and neoplasm: Therapeutic strategies, such as VEGF inhibitors (e.g., bevacizumab), have shown promise in normalizing tumor vasculature by pruning immature vessels, stabilizing vessel structures, and improving tumor perfusion (26, 27).